Skip to main content
Log in

The folate receptor in central nervous system malignancies of childhood

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

The folate receptor is a membrane linked glycoprotein that participates in the cellular accumulation of 5-methyltetrahydrofolic acid, methotrexate and 5,10-dideazatetrahydrofolic acid. Relative receptor overexpression has been observed in several malignant cell lines and tissues. In this study we determined receptor expression using western blot analysis in primary pediatrie malignancies involving the central nervous system. This study suggests that ependymoma tumors have a high frequency of receptor expression which may reflect a specific cytogenetic abnormality or the cellular origin of these tumors. The potential role in developing selective chemotherapy mediated by the folate receptor is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andersen RGW, Kamen BA, Rothberg KG, Lacey SW: Potocytosis: sequestration and transport of small molecules by caveola. Science 255: 410–411, 1992

    PubMed  Google Scholar 

  2. Ratnam M, Marquardt H, Duhring JL, Freisheim JH: Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA. Biochemistry 28: 8249–8254, 1989

    PubMed  Google Scholar 

  3. Page ST, Owen WC, Price K, Elwood PC: Expression of the human placental folate receptor transcript is regulated in human tissues. Organization and full nucleotide sequence of the gene. J Mol Biol 229:1175–1183, 1993

    PubMed  Google Scholar 

  4. Brigle KE, Westin EH, Houghton MT, Goldman ID: Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. J Biol Chem 266:17243–17249, 1991

    PubMed  Google Scholar 

  5. Sadasivan E, Cedeno M, Rothenberg P: Genomic organization of the gene and a related pseudogene for a human binding protein. Biochem Biophys Acta 1131: 91–94, 1992

    PubMed  Google Scholar 

  6. Matsue H, Rothberg KG, Takashima A, Kamen BA, Anderson RGW, Lacey SW: Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc Natl Acad Sci 89: 6006–6009, 1992

    PubMed  Google Scholar 

  7. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Kamen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52: 3396–3401, 1992

    PubMed  Google Scholar 

  8. Rothenberg SP, DaCosta M: Further observations on the folate binding factor in some leukemic cells. J Clin Invest 50: 719–726, 1971

    PubMed  Google Scholar 

  9. Corrocher R, Pachor ML, Bambara LM, Stanzial AM, Biasi D, Sandre GD: Serum folate binding capacity in patients with solid tumors. Tumori 67:101–104, 1981

    PubMed  Google Scholar 

  10. Willis SA, Lacey SW, Weitman SD, Kamen BA, Nisen PD: Folate receptor gene expression is tissue-specific and temporally-regulated. Cancer Ther Control 2: 223–230, 1992

    Google Scholar 

  11. Miotti S, Canevari S, Menard S, Mezzanzanica D, Porro G, Pupa SM, Regazzoni M, Tagliabue E, Colnaghi MI: Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor restricted specificity. Int J Cancer 39: 297–303, 1987

    PubMed  Google Scholar 

  12. Alberti S, Miotti M, Fornaro M, Mantovani S, Canevari S, Menard S, Colnaghi ML: Xhe CA-MOv 18 molecule, a cellsurface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositol. Biochem Biophys Res Commun 17:1051–1055, 1990

    Google Scholar 

  13. Campbell IG, Jones T, Foulkes WD, Trowsdale J: High-affinity folate binding protein is a marker for ovarian cancer. Cancer Res 51:5329–5338, 1991

    PubMed  Google Scholar 

  14. Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA: Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis. Cancer Res 52: 6708–6711, 1992

    PubMed  Google Scholar 

  15. Colman N, Herbert V: Folates and the nervous system. In: Blakley RL, Whitehead VM (eds) Folates and Pterins. John Wiley and Sons Inc., New York 339–357, 1986

    Google Scholar 

  16. Antony AC: The biological chemistry of folate receptors. Blood 79: 2807–2820, 1992

    PubMed  Google Scholar 

  17. Pizzorno G, Cashmore AR, Moroson BA, Cross AD, Smith AK, Marling-Cason M, Kamen BA, Beardsley GP: 5,10-dideazatetrahydrofolic acid (DDATHF) transport in CCRFCEM and MA104 cell lines. J Biol Chem 268: 1017–1023, 1993

    PubMed  Google Scholar 

  18. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76:4350–4354, 1979

    PubMed  Google Scholar 

  19. Zwiener RJ, Johnson CA, Anderson RGW, Kamen BA: Purified folate receptor-5-methyltetrahydrofolic acid interaction at neutral and acid pH. Cancer Res Ther Control 3:37–42, 1992

    Google Scholar 

  20. Kamen BA, Gaston JD: Properties of a folate binding protein (FBP) isolated from porcine kidney. Biochem Pharmacol 35: 2323–2329, 1986

    PubMed  Google Scholar 

  21. Antony AC, Utley C, Van Horne KC, Kolhouse JF: Isolation and characterization of a folate receptor from human placenta. J Biol Chem 256: 9684–9692, 1984

    Google Scholar 

  22. Mihara Y, Matsukado Y, Goto S, Ushio Y, Tokumitsu S, Takahashi K: Monoclonal antibody against ependymoma-dedrived cell line. J Neuro-Oncol 12:1–11, 1992

    Google Scholar 

  23. Sainati L, Montaldi A, Putti MC, Giangaspero F, Rigobello L, Stella M, Zanesco L, Basso G: Cytogenetic t(11;17) (q13;21) in a pediatrie ependymoma. Cancer Genet Cytogenet 59: 213–216, 1992

    PubMed  Google Scholar 

  24. Dal Cin P, Sandberg AA: Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 30: 289–293, 1988

    PubMed  Google Scholar 

  25. Berenson JR, Yang J, Mickle RA: Frequent amplification of thebcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4: 1111–1116, 1989

    PubMed  Google Scholar 

  26. Ali IU, Merlo G, Callahan R, Lidereau R: The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails thebcl-1, int-2 andhost loci. Oncogene 4: 89–92, 1989

    PubMed  Google Scholar 

  27. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC: Characterization of a candidatebcl-1 gene. Mol Cell Biol 11: 4846–4853, 1991

    PubMed  Google Scholar 

  28. Mezzanzanica D, Garrido MA, Neblock DS, Daddona PE, Andrew SM, Zurawski VR, Segal DM, Wunderlich JR: Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. Cancer Res 51:5716–5721, 1991

    PubMed  Google Scholar 

  29. Jansen G, Schornagel JH, Westerhof GR, Rijksen G, Newell DR, Jackman AL: Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors. Cancer Res 50: 7544–7548, 1990

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weitman, S.D., Frazier, K.M. & Kamen, B.A. The folate receptor in central nervous system malignancies of childhood. J Neuro-Oncol 21, 107–112 (1994). https://doi.org/10.1007/BF01052894

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01052894

Key words

Navigation